Korea Vaccine to construct WHO standard GMP plant.

Published: 2003-11-19 06:56:00

Updated: 2003-11-19 06:56:00

Korea Vaccine Company (chairman: Huh Chang-wha) announced that a WHO standard GMP plant would be constructed in the pharmaceutical plant located in Ahnsan city. Green Cross EM, an affiliated company of Green Cross group, will participate in the construction project as a turnkey basis. Korea Vacci...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK